Baxter International (BAX) Total Current Liabilities (2009 - 2026)
Baxter International's (BAX) quarterly Total Current Liabilities came in at $3.6 billion in Q2 2026, up 22.18% year-over-year from $2.9 billion in Q2 2025, and down 2.76% quarter-over-quarter from $3.7 billion in Q1 2026.
Analysis
Baxter International (BAX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Total Current Liabilities for 18 consecutive years, with $3.6 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 22.18% year-over-year to $3.6 billion in Q2 2026; TTM through Jun 2026 was $3.6 billion, a 22.18% increase from a year earlier, with the FY2025 full-year figure at $3.0 billion, down 54.38% from the prior year.
- Total Current Liabilities was $3.6 billion for Q2 2026 at Baxter International, down from $3.7 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $6.5 billion in Q4 2024 and troughed at $2.9 billion in Q2 2025.
- A 5-year average of $4.7 billion and a median of $4.3 billion in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 67.45% in 2023 and sank 54.38% in 2025, its largest moves.
- Over 5 years, Total Current Liabilities stood at $4.7 billion in 2022, then jumped by 37.05% to $6.5 billion in 2023, then climbed by 0.12% to $6.5 billion in 2024, then slumped by 54.38% to $3.0 billion in 2025, then rose by 20.91% to $3.6 billion in 2026.
- The last three Total Current Liabilities figures came in at $3.6 billion (Q2 2026), $3.7 billion (Q1 2026), and $3.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 9.40 Bn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 2.71 Bn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 640.50 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 3.59 Bn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | - |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 34.81 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 11.17 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 13.37 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 4.19 Mn |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 3.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.59 Bn |
| Mar 31, 2026 | 3.69 Bn |
| Dec 31, 2025 | 2.97 Bn |
| Sep 30, 2025 | 3.78 Bn |
| Jun 30, 2025 | 2.94 Bn |
| Mar 31, 2025 | 3.48 Bn |
| Dec 31, 2024 | 6.51 Bn |
| Sep 30, 2024 | 6.20 Bn |
| Jun 30, 2024 | 6.13 Bn |
| Mar 31, 2024 | 6.37 Bn |
| Dec 31, 2023 | 6.50 Bn |
| Sep 30, 2023 | 6.21 Bn |
| Jun 30, 2023 | 5.77 Bn |
| Mar 31, 2023 | 4.76 Bn |
| Dec 31, 2022 | 4.75 Bn |
| Sep 30, 2022 | 3.71 Bn |
| Jun 30, 2022 | 3.92 Bn |
| Mar 31, 2022 | 3.89 Bn |
| Dec 31, 2021 | 4.24 Bn |
| Sep 30, 2021 | 3.44 Bn |